Clinical trial
Novel Therapy for Glucose Intolerance in HIV Disease
NCT02006914 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Therapy for Glucose Intolerance in HIV Disease
- Lead sponsor
- Stony Brook University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- April 30, 2012
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.